Healthier planet. Healthier people.
Climate change poses a major threat to staff, patients, and their communities. This is because there is a direct link between the health of our planet and the health of our people. As a system, we are acting to reduce the harmful gases it puts into the atmosphere. Fewer emissions will mean fewer patients with asthma, heart disease, and cancer. It will also reduce any disruption to the delivery of the care we provide.
We’ll be sharing greener initiatives for the people of the Black Country here.
It’s Ask About Asthma Week - 9-13 September
According to Asthma+Lung UK, the UK has the worst death rate for lung conditions, such as asthma and chronic obstructive pulmonary disease (COPD), in Western Europe. The same data show that the UK’s mortality rate for asthma is twice as high as that of the next worst country in Europe, which is unacceptable given that the National Review of Asthma Deaths (NRAD) reports that two-thirds of these deaths are preventable.
So, why is this the case?
Delays in diagnosis, poor housing, high pollution levels, overuse of short-acting beta-agonists (SABA) and underuse of personalised action plans are some of the reasons given. But — surprisingly — the NRAD’s primary finding was complacency among both healthcare professionals and patients.
Asthma is just not taken seriously enough.
Poor respiratory health has been closely related to deprivation and the Black Country has some of the most deprived neighbourhoods in the UK. Respiratory indicators, such as patients taking six or more SABA inhalers, are higher than the national average in the Black Country ranking 40th/42, providing motivation for action.
In the Black Country, our medicines optimisation team continue to promote the change to low carbon footprint inhalers appropriately. We are working towards targets to reduce prescribing of six or more SABA inhalers and reduce prescribing of high carbon preventer inhalers have been incorporated into the GP prescribing incentive scheme for 2024/2025 for all places across BCICB.
In 2023/2024, a target of 10% reduction in both six or more SABA prescribing and Flutiform (very high carbon impact) inhalers was locally agreed with NHSE. BCICB met both targets- achieving a 22% reduction in items and cost of Flutiform prescribing and a 10.13% reduction in six or more SABA inhaler prescribing.
This year we are working on projects that help educate primary care clinicians on greener inhalers, campaign to tackle SABA overuse, educate patients on the greener inhaler options and increase the return of used, expired and unwanted inhalers to community pharmacies for safe and responsible disposal/recycling.
Find out more about Asthma:
Asthma + Lung UK (asthmaandlung.org.uk)
Share our patient leaflet: SABA Overuse
Sign up to the #AskAboutAsthma Online Webinars:
- #AskAboutAsthma Asthma & Air Pollution Webinar. 9 September 2024
- #AskAboutAsthma primary care webinar. 10 September 2024
- #AskAboutAsthma pharmacy webinar. 10 September 2024
- #AskAboutAsthma nursing webinar. 11 September 2024
- #AskAboutAsthma one day conference. 12 September
Improving patient outcomes and reducing carbon emissions for asthma patients
NHS England has also developed a short animation for clinicians treating patients with asthma and COPD, explaining how they can improve patient outcomes and reduce carbon emissions through:
- Ensuring early and accurate diagnosis
- Optimising disease control following local or national guidelines
- Carefully selecting an appropriate inhaler using a shared decision-making process with patients
- Asking patients to return all unused or unwanted inhalers to pharmacies for appropriate disposal